Glioblastoma Foundation Announces New Genomic Testing & Research Laboratory

DURHAM, NC - The Glioblastoma Foundation has announced the creation of the Genomic Testing & Research Laboratory slated to open in fall 2024. This facility is designed to transform the treatment landscape for glioblastoma, an aggressive and lethal form of brain cancer, by offering advanced genomic testing and personalized treatment strategies. With survival rates remaining critically low, this initiative is a significant advancement in the fight against brain cancer.

The laboratory will conduct molecular testing to inform personalized treatment plans aimed at improving survival rates and quality of life for patients. Positioned in Durham, NC, it plans to serve patients across the U.S. by analyzing tumor samples and quickly returning results. The lab promises affordable and accessible services, focusing on significantly better outcomes for patients with a typical prognosis of just 12 to 18 months after diagnosis.